C8B
Basic information
Region (hg38): 1:56929207-56974383
Links
Phenotypes
GenCC
Source:
- type II complement component 8 deficiency (Moderate), mode of inheritance: AR
- type II complement component 8 deficiency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Complement component 8 deficiency, type II | AR | Allergy/Immunology/Infectious | Antiinfectious prophylaxis (including related to specific immunization strategies) and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 6822660; 8098723; 9476133; 21270745; 22123893 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (360 variants)
- Inborn_genetic_diseases (85 variants)
- Type_II_complement_component_8_deficiency (26 variants)
- C8B-related_disorder (12 variants)
- Complement_component_6_deficiency (2 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C8B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000066.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 91 | 101 | ||||
missense | 186 | 14 | 202 | |||
nonsense | 14 | 21 | ||||
start loss | 0 | |||||
frameshift | 17 | 18 | ||||
splice donor/acceptor (+/-2bp) | 8 | |||||
Total | 31 | 12 | 192 | 105 | 10 |
Highest pathogenic variant AF is 0.00132238
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C8B | protein_coding | protein_coding | ENST00000371237 | 12 | 36931 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.31e-19 | 0.00372 | 125315 | 0 | 433 | 125748 | 0.00172 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.743 | 351 | 314 | 1.12 | 0.0000176 | 3895 |
Missense in Polyphen | 110 | 100.13 | 1.0985 | 1296 | ||
Synonymous | -2.19 | 146 | 116 | 1.26 | 0.00000674 | 1090 |
Loss of Function | 0.109 | 29 | 29.6 | 0.978 | 0.00000155 | 364 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00309 | 0.00309 |
Ashkenazi Jewish | 0.00129 | 0.00129 |
East Asian | 0.000327 | 0.000326 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.00256 | 0.00256 |
Middle Eastern | 0.000327 | 0.000326 |
South Asian | 0.000555 | 0.000555 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells.;
- Disease
- DISEASE: Complement component 8 deficiency, 2 (C8D2) [MIM:613789]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Prion diseases - Homo sapiens (human);Complement and coagulation cascades - Homo sapiens (human);Systemic lupus erythematosus - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Allograft Rejection;Complement Activation;alternative complement pathway;classical complement pathway;lectin induced complement pathway;Innate Immune System;Immune System;Regulation of Complement cascade;Terminal pathway of complement;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.431
- rvis_EVS
- 0.56
- rvis_percentile_EVS
- 81.67
Haploinsufficiency Scores
- pHI
- 0.0529
- hipred
- N
- hipred_score
- 0.187
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.869
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- C8b
- Phenotype
- hematopoietic system phenotype;
Gene ontology
- Biological process
- immune response;complement activation;complement activation, alternative pathway;complement activation, classical pathway;cytolysis;regulation of complement activation
- Cellular component
- extracellular region;membrane attack complex;membrane;extracellular exosome;extracellular vesicle
- Molecular function
- protein-containing complex binding